(Q54264719)
Statements
F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity. (English)
A Kruczynski
A Pillon
L Créancier
I Vandenberghe
B Gomes
V Brel
E Fournier
J-P Annereau
E Currie
Y Guminski
D Bonnet
C Bailly
N Guilbaud
9 April 2013
27
11
2139-2148
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference